• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dravet 综合征 iPSC 衍生 GABA 能细胞的转录组显示染色质重塑和神经发育相关途径失调。

Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.

机构信息

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Biomedical Centre, Box 815, 751 08 Uppsala, Sweden.

Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Biomedical Centre, Box 815, 751 08 Uppsala, Sweden.

出版信息

Neurobiol Dis. 2019 Dec;132:104583. doi: 10.1016/j.nbd.2019.104583. Epub 2019 Aug 21.

DOI:10.1016/j.nbd.2019.104583
PMID:31445158
Abstract

Dravet syndrome (DS) is an early onset refractory epilepsy typically caused by de novo heterozygous variants in SCN1A encoding the α-subunit of the neuronal sodium channel Na1.1. The syndrome is characterized by age-related progression of seizures, cognitive decline and movement disorders. We hypothesized that the distinct neurodevelopmental features in DS are caused by the disruption of molecular pathways in Na1.1 haploinsufficient cells resulting in perturbed neural differentiation and maturation. Here, we established DS-patient and control induced pluripotent stem cell derived neural progenitor cells (iPSC NPC) and GABAergic inter-neuronal (iPSC GABA) cells. The DS-patient iPSC GABA cells showed a shift in sodium current activation and a perturbed response to induced oxidative stress. Transcriptome analysis revealed specific dysregulations of genes for chromatin structure, mitotic progression, neural plasticity and excitability in DS-patient iPSC NPCs and DS-patient iPSC GABA cells versus controls. The transcription factors FOXM1 and E2F1, positive regulators of the disrupted pathways for histone modification and cell cycle regulation, were markedly up-regulated in DS-iPSC GABA lines. Our study highlights transcriptional changes and disrupted pathways of chromatin remodeling in Na1.1 haploinsufficient GABAergic cells, providing a molecular framework that overlaps with that of neurodevelopmental disorders and other epilepsies.

摘要

德拉维特综合征(DS)是一种早期发病的难治性癫痫,通常由编码神经元钠离子通道 Na1.1 的α亚单位 SCN1A 的从头杂合变异引起。该综合征的特征是癫痫发作、认知能力下降和运动障碍随年龄进展。我们假设 DS 中独特的神经发育特征是由于 Na1.1 单倍不足细胞中分子途径的破坏导致神经分化和成熟受到干扰而引起的。在这里,我们建立了 DS 患者和对照诱导多能干细胞衍生的神经祖细胞(iPSC NPC)和 GABA 能中间神经元(iPSC GABA)细胞。DS 患者的 iPSC GABA 细胞表现出钠离子电流激活的偏移和对诱导氧化应激的反应失调。转录组分析显示,与对照相比,DS 患者的 iPSC NPC 和 DS 患者的 iPSC GABA 细胞中存在染色质结构、有丝分裂进展、神经可塑性和兴奋性相关基因的特异性失调。转录因子 FOXM1 和 E2F1 是组蛋白修饰和细胞周期调节中断途径的正调控因子,在 DS-iPSC GABA 系中明显上调。我们的研究强调了 Na1.1 单倍不足的 GABA 能细胞中染色质重塑的转录变化和中断途径,为重叠的神经发育障碍和其他癫痫提供了一个分子框架。

相似文献

1
Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.Dravet 综合征 iPSC 衍生 GABA 能细胞的转录组显示染色质重塑和神经发育相关途径失调。
Neurobiol Dis. 2019 Dec;132:104583. doi: 10.1016/j.nbd.2019.104583. Epub 2019 Aug 21.
2
Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications.Dravet 综合征 iPSC 中 GABA 能发育的表观遗传学见解及其治疗意义。
Elife. 2024 Aug 27;12:RP92599. doi: 10.7554/eLife.92599.
3
Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.来自德雷维特综合征患者的GABA能神经元中不同SCN1A突变对钠电流损伤的差异影响。
Brain Dev. 2018 Apr;40(4):287-298. doi: 10.1016/j.braindev.2017.12.002. Epub 2017 Dec 30.
4
Generation of three human induced pluripotent stem cell (iPSC) lines from three patients with Dravet syndrome carrying distinct SCN1A gene mutations.从三名携带不同SCN1A基因突变的Dravet综合征患者中生成三个人诱导多能干细胞(iPSC)系。
Stem Cell Res. 2019 Aug;39:101523. doi: 10.1016/j.scr.2019.101523. Epub 2019 Jul 31.
5
Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.Dravet 综合征患者来源神经元提示一种新的癫痫发病机制。
Ann Neurol. 2013 Jul;74(1):128-39. doi: 10.1002/ana.23897. Epub 2013 Jul 2.
6
Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.从患有SCN1A突变嵌合体的个体中建立同基因诱导多能干细胞,作为研究德拉韦特综合征神经认知障碍的模型。
J Hum Genet. 2016 Jun;61(6):565-9. doi: 10.1038/jhg.2016.5. Epub 2016 Feb 4.
7
Generation of a human iPSC line (UUIGPi015-A) from a patient with Dravet syndrome and a 2.9 Mb deletion spanning SCN1A on chromosome 2.从一名患有Dravet综合征且2号染色体上存在跨越SCN1A基因的2.9兆碱基缺失的患者身上生成了一条人诱导多能干细胞系(UUIGPi015-A)。
Stem Cell Res. 2022 Apr;60:102712. doi: 10.1016/j.scr.2022.102712. Epub 2022 Feb 16.
8
Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes.通道病作为 Dravet 综合征患者来源的心肌细胞中 SUDEP 的生物标志物。
Stem Cell Reports. 2018 Sep 11;11(3):626-634. doi: 10.1016/j.stemcr.2018.07.012. Epub 2018 Aug 23.
9
Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.Dravet 综合征小鼠模型中海马尖波涟漪的损伤。
J Neurosci. 2019 Nov 13;39(46):9251-9260. doi: 10.1523/JNEUROSCI.0890-19.2019. Epub 2019 Sep 19.
10
The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model.从三位患有德拉维特综合征的个体中生成人类诱导多能干细胞系,并对 iPSC 衍生的脑室下脑器官模型中的神经分化标志物进行特征描述。
Cells. 2023 Jan 16;12(2):339. doi: 10.3390/cells12020339.

引用本文的文献

1
Dravet syndrome: novel insights into -mediated epileptic neurodevelopmental disorders within the molecular diagnostic-therapeutic framework.德拉韦特综合征:分子诊断 - 治疗框架内对介导的癫痫性神经发育障碍的新见解。
Front Neurosci. 2025 Jul 23;19:1634718. doi: 10.3389/fnins.2025.1634718. eCollection 2025.
2
Knock, Knock, Who's There? Not in Brain Organoids.敲,敲,谁呀?不在脑类器官里。
Epilepsy Curr. 2025 Jan 7;25(2):133-135. doi: 10.1177/15357597241308665. eCollection 2025 Mar-Apr.
3
NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2.
NaV1.1 通过调节 AKT 和 CDK2 促进人骨髓间充质干细胞的细胞周期。
J Cell Sci. 2024 Oct 1;137(19). doi: 10.1242/jcs.261732. Epub 2024 Oct 10.
4
Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications.Dravet 综合征 iPSC 中 GABA 能发育的表观遗传学见解及其治疗意义。
Elife. 2024 Aug 27;12:RP92599. doi: 10.7554/eLife.92599.
5
A Novel Ubiquitin Ligase Adaptor PTPRN Suppresses Seizure Susceptibility through Endocytosis of Na1.2 Sodium Channels.一种新型泛素连接酶接头蛋白 PTPRN 通过内吞作用抑制 Na1.2 钠通道从而降低癫痫易感性。
Adv Sci (Weinh). 2024 Aug;11(29):e2400560. doi: 10.1002/advs.202400560. Epub 2024 Jun 14.
6
Generation of iPSC lines (KAIMRCi003A, KAIMRCi003B) from a Saudi patient with Dravet syndrome carrying homozygous mutation in the CPLX1 gene and heterozygous mutation in SCN9A.从一名患有德拉韦特综合征的沙特患者中生成诱导多能干细胞系(KAIMRCi003A,KAIMRCi003B),该患者携带 CPLX1 基因的纯合突变和 SCN9A 的杂合突变。
Hum Cell. 2024 Mar;37(2):502-510. doi: 10.1007/s13577-023-01016-z. Epub 2023 Dec 19.
7
Strategies for dissecting the complexity of neurodevelopmental disorders.剖析神经发育障碍复杂性的策略。
Trends Genet. 2024 Feb;40(2):187-202. doi: 10.1016/j.tig.2023.10.009. Epub 2023 Nov 8.
8
Identification of key potassium channel genes of temporal lobe epilepsy by bioinformatics analyses and experimental verification.通过生物信息学分析和实验验证鉴定颞叶癫痫的关键钾通道基因
Front Neurol. 2023 Jul 7;14:1175007. doi: 10.3389/fneur.2023.1175007. eCollection 2023.
9
Engineering considerations of iPSC-based personalized medicine.基于诱导多能干细胞的个性化医疗的工程学考量
Biomater Res. 2023 Jul 7;27(1):67. doi: 10.1186/s40824-023-00382-x.
10
Ion channels in neurodevelopment: lessons from the Integrin-KCNB1 channel complex.神经发育中的离子通道:来自整合素-KCNB1通道复合物的启示。
Neural Regen Res. 2023 Nov;18(11):2365-2369. doi: 10.4103/1673-5374.371347.